Single-Institution Series of Early-Stage Merkel Cell Carcinoma: Long-Term Outcomes in 95 Patients Managed With Surgery Alone

Ann Surg Oncol. 2009 Jul 18;16(11):2985-2993, E Bajetta, L Celio, M Platania, S Lo Vullo, R Patuzzo, A Maurichi, M Santinami

TAKE-HOME MESSAGE

Abstract

SUMMARY

OncologySTAT Editorial Team

Merkel cell carcinoma (MCC) has tripled in incidence over the past 15 years. This increase has been attributed primarily to improved diagnostic techniques but also to an aging population that has had extensive sun exposure and an increased risk of suppressed immunity. MCC often displays an aggressive course, with a high mortality rate in patients with metastatic disease. However, there is significant variability in treatment patterns for this disease. Because MCC is a relatively rare disease, no...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration